Volume 6, Issue 2, March 2020, Page: 25-27
Myofibroblastic Inflammatory Bowel Tumor: Unusual location, Case Report
Khalid Gharbi, Gastroenterology Service, Hospital Mohammed VI, Marrakech, Morocco
Mohammed Amine Lkousse, Gastroenterology Service, Hospital Mohammed VI, Marrakech, Morocco
Jamal Atmani, Gastroenterology Service, Hospital Mohammed VI, Marrakech, Morocco
Younes Ismail, Gastroenterology Service, Hospital Mohammed VI, Marrakech, Morocco
Abdeltif Elfarouki, Gastroenterology Service, Hospital Mohammed VI, Marrakech, Morocco
Adil Ait Errami Adil Ait Errami, Gastroenterology Service, Hospital Mohammed VI, Marrakech, Morocco
Sofia Oubaha, Gastroenterology Service, Hospital Mohammed VI, Marrakech, Morocco
Zohor Samlani, Gastroenterology Service, Hospital Mohammed VI, Marrakech, Morocco
Khadija Krati, Gastroenterology Service, Hospital Mohammed VI, Marrakech, Morocco
Received: Jan. 15, 2020;       Accepted: Feb. 10, 2020;       Published: Jun. 4, 2020
DOI: 10.11648/j.ijcems.20200602.12      View  49      Downloads  18
Abstract
Inflammatory myofibroblastic tumours (IMT) are unusual benign tumours, also known as inflammatory pseudotumours, represent a group of fibro-inflammatory lesions of recent individualization. They are mesenchymal tumours of intermediate class, very rare and of unknown etiology. They are initially described in the lungs, but have been observed in several other locations, mainly abdominal and pelvic. Its location in the colon is exceptional. The evolutionary doubt of these tumours requires regular and long term follow-up. We report the case of a 30-year-old patient who presented with a stenosing caecal mass. After surgical removal, histological and immunohistochemical examination was in favor of a colonic (IMT). The clinical, radiological and histological characteristics of this anatomoclinical entity will be discussed in light of the data in the literature.
Keywords
Inflammatory Myofibroblastic Tumor, Pseudotumor, Benign, Immunohistochemistry
To cite this article
Khalid Gharbi, Mohammed Amine Lkousse, Jamal Atmani, Younes Ismail, Abdeltif Elfarouki, Adil Ait Errami Adil Ait Errami, Sofia Oubaha, Zohor Samlani, Khadija Krati, Myofibroblastic Inflammatory Bowel Tumor: Unusual location, Case Report, International Journal of Clinical and Experimental Medical Sciences. Vol. 6, No. 2, 2020, pp. 25-27. doi: 10.11648/j.ijcems.20200602.12
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Coffin C M, Watterson J, Priest J R, Dehner L P. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995; 19 (8): 859–872. [PubMed] [Google Scholar].
[2]
Kim E Y, Lee I K, Lee Y S. et al. Inflammatory myofibroblastic tumor in colon. J Korean Surg Soc. 2012; 82 (1): 45–49. [PMC free article] [PubMed] [Google Scholar].
[3]
Narla L D, Newman B, Spottswood S S, Narla S, Kolli R. Inflammatory pseudotumor. Radiographics. 2003; 23 (3): 719–729. [PubMed] [Google Scholar].
[4]
Karnak I, Senocak M E, Ciftci A O. et al. Inflammatory myofibroblastic tumor in children: diagnosis and treatment. J Pediatr Surg. 2001; 36 (6): 908–912. [PubMed] [Google Scholar].
[5]
Hedlund G L, Navoy J F, Galliani C A, Johnson W H Jr. Aggressive manifestations of inflammatory pulmonary pseudotumor in children. Pediatr Radiol. 1999; 29 (2): 112–116. [PubMed] [Google Scholar].
[6]
Benjamin SP, Hawk WA, Turnbull RB. Fibrous inflammatory polyps of the ileum and cecum review of five cases with emphasisou differentiation from mesenchymal neoplasm. Cancer 1977; 39: 130-5.
[7]
Jougon J, Amar AR. Pseudotumeur inflammatoire de l’appendice à propos d’un cas et revue de la littérature. J Chir 1991; 128: 86-8.
[8]
Levy A. D., Shaw J. C., Sobin L. H. Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation Radiographics 2009; 29 (2): 347-373.
[9]
Gleason B. C., Hornick J. L. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 2008; 61 (4): 428-437.
[10]
Coffin cm, Patel A., Perkins S., Elenitoba-Johnson K. S., Perlman E., Griffin C. A. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor Mod Pathol 2001; 14 (6): 569-576.
[11]
Salameh M, Sultan I, Barbar M. et al. Inflammatory myofibroblastic tumor causing unexplained anemia in a toddler: a case report. J Med Case Reports. 2011; 5: 69. [PMC free article] [PubMed] [Google Scholar].
[12]
Miettinen M, Sobin L H, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT) Mod Pathol. 2000; 13 (10): 1134–1142. [PubMed] [Google Scholar].
[13]
Maiga MY. Pseudotumeur inflammatoire du foie: à propos d’un cas. Annales de Chirurgie 2003; 128: 273-4.
[14]
Coffin CM, Watterson J, Priest J R, Dehner LP. Extrapulmonary inflammatory myofibroblastique tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochimical study of 84 cases. Am J of Surg Pathol 1995; 19: 859-72.
Browse journals by subject